On Invalid Date, Mind Medicine (NASDAQ: MNMD) reported Q2 2023 earnings per share (EPS) of -$0.76, up 26.67% year over year. Total Mind Medicine earnings for the quarter were -$29.13 million. In the same quarter last year, Mind Medicine's earnings per share (EPS) was -$0.60.
As of Q3 2023, Mind Medicine's earnings has grown year over year. Mind Medicine's earnings in the past year totalled -$75.33 million.
What is MNMD's earnings date?
Mind Medicine's earnings date is Invalid Date. Add MNMD to your watchlist to be reminded of MNMD's next earnings announcement.
What was MNMD's revenue last quarter?
On Invalid Date, Mind Medicine (NASDAQ: MNMD) reported Q2 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Mind Medicine's revenue was $0.00.
What was MNMD's revenue growth in the past year?
As of Q3 2023, Mind Medicine's revenue has grown null year over year. Mind Medicine's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.